Custom Assay Development
We provide comprehensive diagnostics solutions. Biomarker assay development services, including protein and nucleic acid based, for most platforms available in the market today.
We design, develop and validate CDx test for drugs under development and for drugs already on the market. R-Biopharm has been developing and commercializing globally successful IVD products for more than 25 years. Specific diagnostic tests are required for pre-clinical and clinical phases of drug development as well as for patient stratification.
For novel protein therapeutics immunoassays are the methods of choice, monitoring concentrations and assessing immunogenicity.
Our broad range of innovative diagnostic systems
R-Biopharm is your partner for development and commercialization of various diagnostic systems:
- Rapid Assays in Point of Care applications
- Real-time Polymerase Chain Reaction (PCR)
- Enzyme-linked immunosorbent assay (ELISA)
- Immunohistochemistry (IHC)
- Microarray Technology